Depending on multi-omics data for TCGA-PAAD cohort, the integrative mutational landscape of pharmacogenomics-classified subtype agreed with published researches that the most frequent mutated genes are KRAS, TP53, CDKN2A, and SMAD4, the four driven factors generally recognized. This evidence concerns the gene KRAS and pancreatic adenocarcinoma.